Results 111 to 120 of about 5,276 (141)

Central Nervous System Aspergillosis: Advances in Diagnosis, Therapeutics, and Multidisciplinary Management (2026 Update)

Mycoses, Volume 69, Issue 9, September 2026.
ABSTRACT Background Central nervous system (CNS) aspergillosis is a life‐threatening infection with mortality rates exceeding 50%, especially in immunocompromised patients. Significant challenges persist due to limited antifungal drug penetration into the CNS, emerging resistance, and diagnostic delays, despite advancements in therapy and diagnostics ...
Moustafa A. Mansour, Mohamed Wahid, Mohamed A. S. El Molla, Mohamed H. Helmy, Taha Mohammed Adel, Hamdi Nabawi Mostafa   +5 more
wiley   +1 more source

In vitro activity of aztreonam-avibactam and comparators against Enterobacterales isolated from bloodstream infections: ATLAS/ surveillance, 2021–2022

Microbiology Spectrum
Carbapenem-resistant Enterobacterales (CRE) present a major global health concern due to rapid spread, high mortality, and limited treatment options. Metallo-β-lactamase (MBL)-producing CRE, particularly those harboring New Delhi metallo-β-lactamase (NDM)
Gian Maria Rossolini, Fupin Hu, Nandini Sethuraman, Shweta Kamat, Naglaa Mohamed, Gregory Stone, Katherine K. Perez   +6 more
doaj   +1 more source

Genotypes, Fluconazole Tolerance and Virulence Phenotypes of Candida albicans Bloodstream Isolates: A Multilocus Sequence Typing‐Based Analysis

Mycoses, Volume 69, Issue 9, September 2026.
ABSTRACT Background Fluconazole tolerance is an emerging phenotype in Candida albicans bloodstream infections, but its relationship to multilocus sequence typing (MLST) lineages and virulence traits is unclear. Objectives To investigate the relationships among MLST genotypes, fluconazole tolerance, and virulence phenotypes in C.
Shang‐Yi Lin, Yin‐Tse Huang, Ho‐Yin Huang, Wei‐Chun Hung, Yi‐Ting Tseng, Po‐Liang Lu   +5 more
wiley   +1 more source

Antifungal susceptibility testing in Aspergillus spp. according to EUCAST methodology

, 2006
The availability of new antifungal agents has multiplied the demand for in vitro antifungal susceptibility testing for Aspergillus spp. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) has charged its Antifungal Susceptibility ...
Lass-Flörl, C., Rodriguez-Tudela, J. L., Denning, D. W.; id_orcid, Cuenca-Estrella, M.   +3 more
core   +1 more source

High‐Throughput Sequencing in Aquaculture Disease Investigations: Challenges and Opportunities for Implementation

Reviews in Aquaculture, Volume 18, Issue 4, September 2026.
ABSTRACT The current generation of sequencing technologies can produce terabases of data with exceptional accuracy and speed, at a fraction of the cost of older methods. Despite this unprecedented power, adoption into aquaculture health management presents several challenges, including identifying where such capability may be optimally deployed.
Francisca Samsing, Phoebe Arbon, Matthew Arnold, Andrew C. Barnes, David Bass, Joy A. Becker, Jerusha Bennett, Charles Caraguel, Jeremy Carson, Vincenzo A. Costa, Thomas Dumond, Jemma Geoghegan, Kate S. Hutson, Garry Knowles, Jasmine Knowles, Katherine Lockton, Matthew Pope, Oleksandra Rudenko, Roisin Sullivan, Felix Zareie‐Vaux, Jane Williams, Kerrie Wiley   +21 more
wiley   +1 more source

The EUCAST Disk Diffusion Method for Antimicrobial Susceptibility Testing of Oral Anaerobes [PDF]

There is a need for standardized methods for antimicrobial susceptibility testing (AST) of anaerobic bacteria involved in oral and extra-oral infections.
Nørskov-Lauritsen, Niels, Lau, Ellen Frandsen, Greve, Thomas, Jensen, Anne Birkeholm   +3 more
core   +1 more source

Peer review of the pesticide risk assessment of the active substance Beauveria bassiana strain R444

EFSA Journal, Volume 24, Issue 9, September 2026.
Abstract The conclusions of the EFSA following the peer review of the initial risk assessments carried out by the competent authority of the rapporteur Member State, Denmark, for the pesticide active substance Beauveria bassiana strain R444 and the considerations as regards the inclusion of the substance in Annex IV of Regulation (EC) No 396/2005 are ...
European Food Safety Authority (EFSA), Fernando Álvarez, Maria Arena, Domenica Auteri, Sofia Batista Leite, Marco Binaglia, Anna Federica Castoldi, Arianna Chiusolo, Angelo Colagiorgi, Mathilde Colas, Federica Crivellente, Chloe De Lentdecker, Isabella De Magistris, Mark Egsmose, Gabriella Fait, Franco Ferilli, German Giner Santonja, Varvara Gouliarmou, Alessio Ippolito, Frederique Istace, Dimitra Kardassi, Aude Kienzler, Anna Lanzoni, Roberto Lava, Renata Leuschner, Alberto Linguadoca, Mariano Lopez Romano, Jochem Louisse, Christopher Lythgo, Oriol Magrans, Iris Mangas, Silvia Mazzega, Andrea Mioč, Ileana Miron, Tunde Molnar, Laura Padovani, Vincenzo Padricello, Martina Panzarea, Juan Manuel Parra Morte, Simone Rizzuto, Miguel Santos, Rositsa Serafimova, Rachel Sharp, Csaba Szentes, Anne Theobald, Manuela Tiramani, Giorgia Vianello, Laura Villamar‐Bouza   +47 more
wiley   +1 more source

Antimicrobial Susceptibility Testing of the Combination of Aztreonam and Avibactam in NDM-Producing Enterobacterales: A Comparative Evaluation Using the CLSI and EUCAST Methods

Antibiotics
Background: The combination of aztreonam (ATM) and avibactam (AVI) presents an important therapeutic option for carbapenem-resistant Enterobacterales, particularly the NDM-producing Enterobacterales.
Linda Mei-Wah Chan, Doris Yui Ling Lok, River Chun Wai Wong, Alfred Lok-Hang Lee, Ingrid Yu-Ying Cheung, Christopher Koon-Chi Lai, Viola C. Y. Chow   +6 more
doaj   +1 more source

Does the adoption of EUCAST susceptibility breackpoints affects the selection of antimicrobials to treat acute community-acquired respiratory tract infections?

, 2012
BACKGROUND: In several European Countries, by the end of 2012, CLSI guidelines will be replaced by EUCAST. We compared antimicrobial susceptibility results of a large number of respiratory pathogens using both EUCAST and previously adopted CLSI criteria ...
BARBIERI, RAMONA, MARCHESE, ANNA, DEBBIA, EUGENIO, Espoito S., Bassetti M.   +4 more
core   +1 more source

Comparison of the ATB® Fungus 2 with the AFST-EUCAST for in vitro susceptibility testing of Candida spp

Salud UIS, 2014
The increase of diseases caused by Candida spp., and the treatment failures, has underscored the need for testing the susceptibilities to antifungal agents. The commercial panel ATB® Fungus 2 was compared with the reference testing method of the European
Jehidys Estella Montiel Ramos, Andrea Corrales Bernal, María Paulina Vélez Bravo, Armando Baena Zapata, Ana Cecilia Mesa Arango   +4 more
doaj